Back
Forrester Research 10K Form
Sell
30
FORR
Forrester Research
Last Price:
$10.61
Seasonality Move:
0.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | FORR/Forrester Research Quarterly |
2023-11-08 | 10Q | FORR/Forrester Research Quarterly |
2023-08-09 | 10Q | FORR/Forrester Research Quarterly |
2023-05-09 | 10Q | FORR/Forrester Research Quarterly |
2022-11-04 | 10Q | FORR/Forrester Research Quarterly |
2022-08-05 | 10Q | FORR/Forrester Research Quarterly |
Receive FORR News And Ratings
See the #1 stock for the next 7 days that we like better than FORR
FORR Financial Statistics
Sales & Book Value
Annual Sales: | $432.5M |
---|---|
Cash Flow: | $26.1M |
Price / Cash Flow: | 10.27 |
Annual Sales: | $7.77 |
Price / Book: | 1.37 |
Profitability
EPS (TTM): | -4.57000 |
---|---|
Net Income (TTM): | $-86.3M |
Gross Margin: | $249.9M |
Return on Equity: | -40% |
Return on Assets: | -17.07% |
Forrester Research Earnings Forecast
Key Forrester Research Financial Ratios
-
The Gross Profit Margin over the past 30 years for FORR is 57.79%.
-
The Selling, General & Administrative Expenses for FORR have been equal to 50.51% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of FORR is -1.33% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 19 years.
Forrester Research Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | FORR |
CUSIP: | 346563 |
Website: | forrester.com |
Debt
Debt-to-Equity Ratio: | 0.24 |
---|---|
Current Ratio: | 0.98 |
Quick Ratio: | 0.79 |
Price-to-Earnings
Trailing P/E Ratio: | 94.38 |
---|---|
Forward P/E Ratio: | 7 |
FORR Technical Analysis vs Fundamental Analysis
Sell
30
Forrester Research (FORR)
is a Sell
Is Forrester Research a Buy or a Sell?
-
Forrester Research stock is rated a SellThe current Forrester Research [FORR] share price is $10.61. The Score for FORR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.